Fig. 1Virologic response of pegylated interferon and ribavirin. RVR 61.8%, EVR 82.5%, ETR 88.9%, SVR 80.5%.
Table 1Baseline characteristics of study population
Table 2The SVR according to RVR, EVR, EVR
Table 3Odds ratio of several factors
Table 4Factors influencing on SVR from univariate analysis
Table 5Adverse events of therapy